Audrey Belkin

I lead global marketing and commercial strategy with a focus on innovation strategy, whitespace identification, and early-stage concept development—backed by portfolios exceeding $500M and budgets up to $200M. I’m known for translating consumer insights into foundational brand narratives, positioning frameworks, and future-forward strategies that revitalize brands and drive sustained growth.

At Bayer Consumer Health, I served as a senior commercial and marketing leader overseeing global Rx-to-OTC switch programs—from early concept through FDA submission and commercialization. I bridged regulatory rigor with consumer-led brand strategy to unlock $100M+ growth opportunities in highly regulated markets, partnering with cross-functional teams of up to 30 across R&D, Marketing, Regulatory, Legal, Clinical, Packaging, Product Supply, and Finance.

My work consistently turns insight into execution: I led three high-level global Rx-to-OTC switch programs, directed clinical and regulatory development plans, and shaped messaging frameworks through segmentation, ethnography, and behavioral research. I also strengthened business cases for OTC and beauty categories by integrating consumer insights, market trends, and competitive analysis to secure investment and executive alignment.

Before that, I drove brand reinvention and turnaround results at Merck Consumer Care—leading a Dr. Scholl’s brand turnaround with a 9-person team delivering 12% sales growth, increasing brand equity by 26%, and delivering $700K+ in savings via Six Sigma-led process improvements. Today, I’m expanding my impact as a senior executive and brand strategy consultant, offering fractional and advisory support across brand strategy and hands-on execution for consumer health and wellness clients.